BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/22/2022 9:25:37 AM | Browse: 777 | Download: 2002
 |
Received |
|
2021-05-27 10:24 |
|
Peer-Review Started |
|
2021-05-27 10:27 |
|
First Decision by Editorial Office Director |
|
2021-07-06 02:00 |
|
Return for Revision |
|
2021-07-06 02:00 |
|
Revised |
|
2021-07-21 09:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-01-24 03:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-01-25 03:24 |
|
Articles in Press |
|
2022-01-25 03:24 |
|
Edit the Manuscript by Language Editor |
|
2022-01-21 10:42 |
|
Typeset the Manuscript |
|
2022-02-15 09:28 |
|
Publish the Manuscript Online |
|
2022-02-22 09:25 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Edda Russo, Camila Fiorindi, Francesco Giudici and Amedeo Amedei |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| ECCO 2021 |
|
|
| Corresponding Author |
Amedeo Amedei, PhD, Professor, Department of Experimental and Clinical Medicine, University of Florence, Complesso Cubo, Viale Pieraccini 6, Florence 50134, Tuscany, Italy. amedeo.amedei@unifi.it |
| Key Words |
Hepatocellular carcinoma; Gut microbiota; Probiotics; Prebiotics; Gut-liver axis; Immunomodulation |
| Core Tip |
In patients with chronic liver disease and cirrhosis, hepatocellular carcinoma (HCC) is the most common primary malignancy. Recent attention has been paid to the involvement of the gut-liver axis (GLA) in HCC pathogenesis. This review explores the potential for new treatment options as a result of novel insights into the processes by which microbiota immunomodulation, represented by probiotics and prebiotics, affects HCC through the GLA. |
| Publish Date |
2022-02-22 09:25 |
| Citation |
Russo E, Fiorindi C, Giudici F, Amedei A. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma. World J Hepatol 2022; 14(2): 372-385 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i2/372.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i2.372 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
